New Strategy for Minimally Invasive Endoscopic Surgery to Treat Infectious Spondylodiscitis in the Thoracolumbar Spine.


Journal

Pain physician
ISSN: 2150-1149
Titre abrégé: Pain Physician
Pays: United States
ID NLM: 100954394

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 2 6 2019
pubmed: 4 6 2019
medline: 21 12 2019
Statut: ppublish

Résumé

Eradicating infection, protecting neurologic function, and maintaining structural alignment are the 3 objectives of treatment for infectious spondylodiscitis. For some patients, surgery may be necessary to achieve these goals; however, open surgeries are associated with high morbidity and mortality in elderly patients and those with multiple comorbidities. Endoscopic surgery provides a minimally invasive surgical option for obtaining a culture sample to aid identification of pathogens, while also providing a route for adequate decompression and drainage. The clinical results of this study were analyzed. To evaluate the efficacy and safety of spinal endoscopic surgery, the basic characteristics of patients analyzed and their inflammatory markers, pain levels, and local kyphotic angles were recorded before surgery and at regular intervals after surgery. The patients' cultured pathogens and previous antibiotic treatments were also recorded and analyzed. Retrospective observational study (institutional review board: CMUH 105-REC2-101). Inpatient surgery center. From October 2006 to March 2017, of 508 patients who received spinal endoscopic surgery, 60 with infectious spondylodiscitis were treated using this new strategy. All 60 patients underwent plain film radiography and enhanced magnetic resonance imaging of the affected region to obtain evidence of infectious spondylodiscitis. The role of a computed tomography-guided biopsy and some indications for open surgery were replaced with endoscopic surgery. All the patients reported rapid pain relief after endoscopic surgery and antibiotic treatment. No significant changes in sagittal alignment were observed in final follow-up radiography images. Causative pathogens were identified in 34 patients (culture rate: 77.27%) without previous antibiotic treatment. The patients' erythrocyte sedimentation rates and C-reactive protein levels had decreased significantly 3 months after endoscopic surgery. Two patients (3.3%) experienced infection relapse following initial endoscopic surgery; both of them were efficiently resolved through a second round of endoscopic surgery. No surgery-related complications were observed and no open spinal surgery was required during the follow-up period. This was a retrospective study; bias was unavoidable because of the single-center nature of the study design. Regarding the culture rate, recurrence rate, kyphotic change, and surgery-related complications, this new strategy for endoscopic surgery is safe and effective for treating infectious spondylodiscitis in the thoracic or lumbar spine and may be considered a new trend in treating diseases of this type. Spine, endoscopic, discectomy, spondylodiscitis, minimally invasive surgery.

Sections du résumé

BACKGROUND
Eradicating infection, protecting neurologic function, and maintaining structural alignment are the 3 objectives of treatment for infectious spondylodiscitis. For some patients, surgery may be necessary to achieve these goals; however, open surgeries are associated with high morbidity and mortality in elderly patients and those with multiple comorbidities. Endoscopic surgery provides a minimally invasive surgical option for obtaining a culture sample to aid identification of pathogens, while also providing a route for adequate decompression and drainage. The clinical results of this study were analyzed.
OBJECTIVES
To evaluate the efficacy and safety of spinal endoscopic surgery, the basic characteristics of patients analyzed and their inflammatory markers, pain levels, and local kyphotic angles were recorded before surgery and at regular intervals after surgery. The patients' cultured pathogens and previous antibiotic treatments were also recorded and analyzed.
STUDY DESIGN
Retrospective observational study (institutional review board: CMUH 105-REC2-101).
SETTING
Inpatient surgery center.
METHODS
From October 2006 to March 2017, of 508 patients who received spinal endoscopic surgery, 60 with infectious spondylodiscitis were treated using this new strategy. All 60 patients underwent plain film radiography and enhanced magnetic resonance imaging of the affected region to obtain evidence of infectious spondylodiscitis. The role of a computed tomography-guided biopsy and some indications for open surgery were replaced with endoscopic surgery.
RESULTS
All the patients reported rapid pain relief after endoscopic surgery and antibiotic treatment. No significant changes in sagittal alignment were observed in final follow-up radiography images. Causative pathogens were identified in 34 patients (culture rate: 77.27%) without previous antibiotic treatment. The patients' erythrocyte sedimentation rates and C-reactive protein levels had decreased significantly 3 months after endoscopic surgery. Two patients (3.3%) experienced infection relapse following initial endoscopic surgery; both of them were efficiently resolved through a second round of endoscopic surgery. No surgery-related complications were observed and no open spinal surgery was required during the follow-up period.
LIMITATIONS
This was a retrospective study; bias was unavoidable because of the single-center nature of the study design.
CONCLUSIONS
Regarding the culture rate, recurrence rate, kyphotic change, and surgery-related complications, this new strategy for endoscopic surgery is safe and effective for treating infectious spondylodiscitis in the thoracic or lumbar spine and may be considered a new trend in treating diseases of this type.
KEY WORDS
Spine, endoscopic, discectomy, spondylodiscitis, minimally invasive surgery.

Identifiants

pubmed: 31151336

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-293

Auteurs

Chia-Yu Lin (CY)

Department of Orthopaedic Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan, R.O.C.

Chien-Chun Chang (CC)

Department of Orthopaedic Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan, R.O.C.; Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan, R.O.C.

Yen-Jen Chen (YJ)

Department of Orthopaedic Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan, R.O.C.; School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.

Chun-Hao Tsai (CH)

Department of Orthopaedic Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan, R.O.C.; Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan, R.O.C.

Hsi-Kai Tsou (HK)

Functional Neurosurgery Division, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.; Department of Rehabilitation, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli County, Taiwan, R.O.C.

Chih-Sheng Lin (CS)

Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan, R.O.C.

Mao-Wang Ho (MW)

Division of Infectious Disease, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan, R.O.C.

Hsien-Te Chen (HT)

Department of Orthopaedic Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan, R.O.C.; Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan, R.O.C.

Horng-Chaung Hsu (HC)

Department of Orthopaedic Surgery, China Medical University Hospital, China Medical University, Taichung, Taiwan, R.O.C.; School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH